ARCHIVES

NCI Begins Large National Clinical Trial To Validate Biomarker For Lung Cancer

This article is from The Cancer Letter archive.

Vol. 31 No. 10 | October 31, 2008

Download PDF Visit The Full Archive

Related Articles

Isis 3521 Gets Fast-track Status For FDA Review.

December 1, 2000

RFA/PA/Drug Group Announcement Limited

May 6, 1988

FDA Reaction to DCT Proposals ‘Positive,’ But Chabner, Wittes ‘Disappointed’ In That Response

June 17, 1988

In Brief: appropriations Approved; Grants, contracts May Flow Unimpeded; NCI Positions An Issue

December 16, 1977

Statins Associated With Lower Risk Of High-Grade Prostate Cancer

March 25, 2011

FDA Urges Moratorium On Sale, Use of Silicone Breast Implants

January 10, 1992